Results 321 to 330 of about 137,029 (384)

Switching from intravenous to subcutaneous infliximab is safe and feasible in patients with perianal Crohn's disease. [PDF]

Therap Adv Gastroenterol
Wils P, Fumery M, Nachury M, Yzet C, Coban D, Buisson A.   +5 more
europepmc   +1 more source

Disease Clearance in Ulcerative Colitis: A Narrative Review

United European Gastroenterology Journal, Volume 13, Issue 6, Page 902-910, July 2025.
ABSTRACT Ulcerative colitis (UC) is a chronic relapsing disease with significant associated risks such as colectomy, hospitalization, or colorectal cancer. A treat‐to‐target approach that mitigates disease activity and progression from an early stage is needed.
Silvio Danese, Laurent Peyrin‐Biroulet, Vipul Jairath, Ferdinando D'Amico, Shashi Adsul, Christian Agboton, Fernando Magro   +6 more
wiley   +1 more source

Neuro-Behçet's Syndrome: A Case Report. [PDF]

Cureus
LeRoy DI, Ognjanovski E, Menkes S, Kenny K, Konja C.   +4 more
europepmc   +1 more source

Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn’s Disease: Long‐Term Outcomes and Risk Factors for Surgery in a Single‐Center Prospective Observational Study

United European Gastroenterology Journal, Volume 13, Issue 6, Page 958-970, July 2025.
ABSTRACT Background and Aims The long‐term outcomes of enteroscopic balloon dilation for small bowel strictures in patients with Crohn’s disease are not well understood. Although Crohn’s strictures can be classified into web‐like, ulcerated, and spindle‐shaped strictures based on endoscopic findings, the outcomes of enteroscopic balloon dilation ...
Sung Noh Hong, Ji Eun Kim, Eun Ran Kim, Dong Kyung Chang, Young‐Ho Kim   +4 more
wiley   +1 more source

Development and validation of a nomogram for predicting endoscopic healing in crohn's disease patients receiving infliximab treatment. [PDF]

BMC Gastroenterol
Li L, Feng T, Huang X, Zu X, Chen M, Qiu Y.   +5 more
europepmc   +1 more source

Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial

United European Gastroenterology Journal, Volume 13, Issue 6, Page 997-1011, July 2025.
ABSTRACT Background & Aims Previous results showed that combined treatment of biologics and exclusive enteral nutrition (EEN) brought moderate‐to‐severe Crohn's disease patients significant improvements in clinical and endoscopic outcomes. Despite its essential role and favorable safety profile, EEN in the treatment of adult Crohn's disease is ...
Jian Kang, Jing Wang, Juan Su, Wei Wang, Yueyue Lu, Zhishun Tang, Liping Zou, Anning Yin, Jiao Li, Haixia Ren, Qian Zhou, Huipeng Wan, Ping An   +12 more
wiley   +1 more source

Infliximab-induced autoimmune-like hepatitis in a patient with Crohn's disease: a case report. [PDF]

Future Sci OA
Ayadi S, Merhaben S, Hadj Kacem L, Rammeh S, Mensi A, Belhadj Mabrouk E, Zaimi Y, Mouelhi L.   +7 more
europepmc   +1 more source

Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature

International Journal of Rheumatic Diseases, Volume 28, Issue 7, July 2025.
ABSTRACT Objective IgA vasculitis (IgAV) and Kawasaki disease (KD) are the most common forms of childhood vasculitis. Although various factors such as viral infections, genetic factors, and environmental factors are involved in the development of both diseases, their pathogenesis remains unclear.
Sevki Erdem Varol, Cisem Cinar, Nihan Burtecene, Sezgin Sahin, Mehmet Yildiz, Kenan Barut, Haluk Cokugras, Sinem Firtina, Ozgur Kasapcopur, Ayca Kiykim   +9 more
wiley   +1 more source

Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. [PDF]

Clin Exp Med
Aljabri A, Soliman GM, Ramadan YN, Medhat MA, Hetta HF.   +4 more
europepmc   +1 more source

Network Meta‐Analysis: Efficacy of Biological Therapies and Small Molecules as Maintenance Therapy in Ulcerative Colitis

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 1, Page 4-21, July 2025.
This systematic review and network meta‐analysis compares biological therapies and small molecules as maintenance treatments for ulcerative colitis, assessing failure rates across clinical, endoscopic and histological outcomes. Findings reveal differential efficacy in patients naive to or previously exposed to advanced therapies, underscoring the ...
Brigida Barberio, David J. Gracie, Christopher J. Black, Alexander C. Ford   +3 more
wiley   +1 more source